Improving global health
Our faculty researchers study new human vaccines with the ultimate goal of understanding and preventing infectious diseases across the globe. We are particularly interested in new vaccines which hope to prevent or control infectious diseases in developing countries. Our group consists of a diverse team of clinicians, study coordinators, scientists, laboratory personnel, and volunteers. Our human research studies are carefully designed and are performed with rigorous oversight and in the safest possible manner. All studies are approved by the ethics review board (Institutional Review Board, IRB) of the University of Vermont.
Volunteers are central to the mission of the Vaccine Testing Center. We are currently recruiting healthy adults for both inpatient and outpatient vaccine trials. Compensation is available to qualified volunteers. Click here for more information.
Our team runs a fully functioning unit for performing phase I and II vaccine trials and enteric challenge models at the Vaccine Testing Center (VTC). In general, the VTC focuses on the development of vaccines of importance to global health, including typhoid fever, Campylobacter and cholera infections, and dengue viral diseases.
UVM Vaccine Testing Center receives grant for Dengue Fever immunology study from the Bill and Melinda Gates Foundation. For the full article, click here.
Drs. Jon Boyson and Jason Botten join the Vaccine Testing Center on Dengue Immunology Grant with the Gates Foundation.
Dr. Kristen Pierce named Associate Professor.
Dr. Kirkpatrick named ELAM Fellow.
Drs. Kirkpatrick and Pierce publish new Dengue research.
Last modified March 02 2015 11:45 AM